Other Species / Isoforms
  PPP1R2 (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K12-ac
TASHRPIkGILKNKT
0 1
PPP1R2 (human) TASHRPIKGILKNKT K12
PPP1R2 (mouse) TASHRPIKGILKNKT K12
PPP1R2 (rat) TASHRPIkGILKNKT K12-ac
PPP1R2 (rabbit) TASHRPIKGILKNKT K12
S20
GILKNKTSTTSSVVA
0 8
PPP1R2 (human) GILKNKTsTTssMVA S20-p
PPP1R2 (mouse) GILKNKTsAAsPPVV S20-p
PPP1R2 (rat) GILKNKTSTTSSVVA S20
PPP1R2 (rabbit) GILKNKTSSTSSRVA S20
S23
KNKTSTTSSVVASAE
0 12
PPP1R2 (human) KNKTsTTssMVAsAE S23-p
PPP1R2 (mouse) KNKTsAAsPPVVPSA S23-p
PPP1R2 (rat) KNKTSTTSSVVASAE S23
PPP1R2 (rabbit) KNKTSSTSSRVASAE S23
S24
NKTSTTSSVVASAEQ
0 2
PPP1R2 (human) NKTsTTssMVAsAEQ S24-p
PPP1R2 (mouse) NKTsAAsPPVVPSAE P24
PPP1R2 (rat) NKTSTTSSVVASAEQ S24
PPP1R2 (rabbit) NKTSSTSSRVASAEQ S24
S28
TTSSVVASAEQPRRT
0 2
PPP1R2 (human) TTssMVAsAEQPrGN S28-p
PPP1R2 (mouse) AsPPVVPSAEQPRPI S29
PPP1R2 (rat) TTSSVVASAEQPRRT S28
PPP1R2 (rabbit) STSSRVASAEQPRGS S28
R33
VASAEQPRRTVEEEL
0 1
PPP1R2 (human) VAsAEQPrGNVDEEL R33-m1
PPP1R2 (mouse) VPSAEQPRPIVEEEL R34
PPP1R2 (rat) VASAEQPRRTVEEEL R33
PPP1R2 (rabbit) VASAEQPRGSVDEEL R33
S44-p
EEELSKKsQKWDEMN
Upstream
Downstream
2 0
Effects on Modified Protein
  • enzymatic activity, induced
Effects on Biological Processes:
  • neural plasticity
Putative in vivo kinases:
  • caMLCK (human)
Treatment
  • A3
  • APV
  • bicuculline
  • CNQX
  • ML-7
  • nimodipine
  • NMDA
  • p18_peptide
  • TTX
  • wortmannin
PPP1R2 (human) DEELSKKsQKWDEMN S44-p
PPP1R2 (mouse) EEELSKKSQKWDEMN S45
PPP1R2 (rat) EEELSKKsQKWDEMN S44-p
PPP1R2 (rabbit) DEELSKKSQKWDEMN S44
T55
DEMNILATYHPADKD
0 1
PPP1R2 (human) DEMNILAtyHPADKD T55-p
PPP1R2 (mouse) DEMNILATYHPADKD T56
PPP1R2 (rat) DEMNILATYHPADKD T55
PPP1R2 (rabbit) DEMNILATYHPADKD T55
Y56
EMNILATYHPADKDY
0 8
PPP1R2 (human) EMNILAtyHPADKDy Y56-p
PPP1R2 (mouse) EMNILATYHPADKDy Y57
PPP1R2 (rat) EMNILATYHPADKDY Y56
PPP1R2 (rabbit) EMNILATYHPADKDY Y56
Y63
YHPADKDYGLMKIDE
0 30
PPP1R2 (human) yHPADKDyGLMKIDE Y63-p
PPP1R2 (mouse) YHPADKDyGLMKIDE Y64-p
PPP1R2 (rat) YHPADKDYGLMKIDE Y63
PPP1R2 (rabbit) YHPADKDYGLMKIDE Y63
D72
LMKIDEPDtPYHNMI
2 0
PPP1R2 (human) LMKIDEPstPyHSMM S72-p
PPP1R2 (mouse) LMKIDEPNtPYHNMI N73
PPP1R2 (rat) LMKIDEPDtPYHNMI D72
PPP1R2 (rabbit) LMKIDEPStPYHSMI S72
T73-p
MKIDEPDtPYHNMIG
Upstream
Downstream
11 3
Effects on Modified Protein
  • molecular association, regulation
Treatment
  • NMDA
  • resveratrol
  • SB415286
PPP1R2 (human) MKIDEPstPyHSMMG T73-p
PPP1R2 (mouse) MKIDEPNtPYHNMIG T74-p
PPP1R2 (rat) MKIDEPDtPYHNMIG T73-p
PPP1R2 (rabbit) MKIDEPStPYHSMIG T73-p
Y75
IDEPDtPYHNMIGDD
0 6
PPP1R2 (human) IDEPstPyHSMMGDD Y75-p
PPP1R2 (mouse) IDEPNtPYHNMIGDD Y76
PPP1R2 (rat) IDEPDtPYHNMIGDD Y75
PPP1R2 (rabbit) IDEPStPYHSMIGDD Y75
C86
IGDDEDVCsDSEGNE
0 3
PPP1R2 (human) MGDDEDACsDtEAtE C86
PPP1R2 (mouse) IGDDEDAysDsEGNE Y87-p
PPP1R2 (rat) IGDDEDVCsDSEGNE C86
PPP1R2 (rabbit) IGDDDDAYsDTETTE Y86
S87-p
GDDEDVCsDSEGNEV
4 18
PPP1R2 (human) GDDEDACsDtEAtEA S87-p
PPP1R2 (mouse) GDDEDAysDsEGNEV S88-p
PPP1R2 (rat) GDDEDVCsDSEGNEV S87-p
PPP1R2 (rabbit) GDDDDAYsDTETTEA S87-p
S89
DEDVCsDSEGNEVMT
0 7
PPP1R2 (human) DEDACsDtEAtEAMA T89-p
PPP1R2 (mouse) DEDAysDsEGNEVMt S90-p
PPP1R2 (rat) DEDVCsDSEGNEVMT S89
PPP1R2 (rabbit) DDDAYsDTETTEAMT T89
N92
VCsDSEGNEVMTPEI
0 1
PPP1R2 (human) ACsDtEAtEAMAPDI T92-p
PPP1R2 (mouse) AysDsEGNEVMtPDI N93
PPP1R2 (rat) VCsDSEGNEVMTPEI N92
PPP1R2 (rabbit) AYsDTETTEAMTPDT T92
T96
SEGNEVMTPEILAKK
0 2
PPP1R2 (human) tEAtEAMAPDILARK A96
PPP1R2 (mouse) sEGNEVMtPDILAKK T97-p
PPP1R2 (rat) SEGNEVMTPEILAKK T96
PPP1R2 (rabbit) TETTEAMTPDTLAKK T96
F114
AEGSEPKFRTREQEs
0 4
PPP1R2 (human) AEGLEPKyRIQEQEs Y114-p
PPP1R2 (mouse) AEGSEPKYRtREQEs Y115
PPP1R2 (rat) AEGSEPKFRTREQEs F114
PPP1R2 (rabbit) AEGSEPKYRIREQEs Y114
T116
GSEPKFRTREQEssG
0 1
PPP1R2 (human) GLEPKyRIQEQEssG I116
PPP1R2 (mouse) GSEPKYRtREQEssG T117-p
PPP1R2 (rat) GSEPKFRTREQEssG T116
PPP1R2 (rabbit) GSEPKYRIREQEssG I116
S121-p
FRTREQEssGEEDND
Upstream
3 101
Treatment
  • corticosterone
  • ethanol
  • sucrose
PPP1R2 (human) yRIQEQEssGEEDsD S121-p
PPP1R2 (mouse) YRtREQEssGEEDND S122-p
PPP1R2 (rat) FRTREQEssGEEDND S121-p
PPP1R2 (rabbit) YRIREQEssGEEDSD S121-p
S122-p
RTREQEssGEEDNDL
Upstream
3 103
Treatment
  • corticosterone
  • ethanol
  • sucrose
PPP1R2 (human) RIQEQEssGEEDsDL S122-p
PPP1R2 (mouse) RtREQEssGEEDNDL S123-p
PPP1R2 (rat) RTREQEssGEEDNDL S122-p
PPP1R2 (rabbit) RIREQEssGEEDSDL S122-p
N127
EssGEEDNDLsPEER
1 9
PPP1R2 (human) EssGEEDsDLsPEER S127-p
PPP1R2 (mouse) EssGEEDNDLsPEER N128
PPP1R2 (rat) EssGEEDNDLsPEER N127
PPP1R2 (rabbit) EssGEEDSDLSPEER S127
S130-p
GEEDNDLsPEEREKK
0 29
PPP1R2 (human) GEEDsDLsPEEREKK S130-p
PPP1R2 (mouse) GEEDNDLsPEEREKK S131-p
PPP1R2 (rat) GEEDNDLsPEEREKK S130-p
PPP1R2 (rabbit) GEEDSDLSPEEREKK S130
Y148
EMKRKLHYNEGLNIk
0 28
PPP1R2 (human) EMKRKLHyNEGLNIk Y148-p
PPP1R2 (mouse) EMKRKLHyNEGLNIK Y149-p
PPP1R2 (rat) EMKRKLHYNEGLNIk Y148
PPP1R2 (rabbit) EMKRKLHYNEGLNIK Y148
K155-ac
YNEGLNIkLARQLIS
0 2
PPP1R2 (human) yNEGLNIkLARQLIS K155-ac
PPP1R2 (mouse) yNEGLNIKLARQLIS K156
PPP1R2 (rat) YNEGLNIkLARQLIS K155-ac
PPP1R2 (rabbit) YNEGLNIKLARQLIS K155
K163-ac
LARQLISkDLHDDDE
0 1
PPP1R2 (human) LARQLISKDLHDDDE K163
PPP1R2 (mouse) LARQLISKDLHDDDE K164
PPP1R2 (rat) LARQLISkDLHDDDE K163-ac
PPP1R2 (rabbit) LARQLISKDLHDDEE K163